15 Wealth Advisors’s AbbVie ABBV Stock Holding History

15 Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.37M	Buy	+16,689	New	+$4.28M	1.09%	23

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $24.1B AUM 30.72% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

15 Wealth Advisors's ABBV Position: Q3 2026 in Review

15 Wealth Advisors opened a new position in AbbVie (ABBV) in Q3 2026: 16,689 shares worth $4.37M. The stake represents 1.09% of the portfolio and ranks #23 among its holdings.

2,139 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

15 Wealth Advisors held 16,689 shares of AbbVie worth $4.37M as of Q3 2026.
AbbVie was a new 15 Wealth Advisors position in Q3 2026.
AbbVie made up 1.09% of 15 Wealth Advisors's portfolio in Q3 2026, its #23 holding.
2,139 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on 15 Wealth Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.